Related Experiment Video
Updated: Jan 4, 2026

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis
Published on: July 28, 2023
GIP and the gut-bone axis - Physiological, pathophysiological and potential therapeutic implications.
Signe Stensen1, Lærke Smidt Gasbjerg2, Mads Marstrand Helsted1
1Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Glucose-dependent insulinotropic polypeptide (GIP), a gut hormone, influences bone remodeling. Research highlights GIP
Area of Science:
- Endocrinology
- Bone Biology
- Gastroenterology
Background:
- The enteroendocrine-osseous axis, involving gut hormones and bone, is a growing research area.
- Glucose-dependent insulinotropic polypeptide (GIP) is a key gut hormone regulating glucose metabolism and insulin secretion.
- Emerging evidence suggests GIP plays a significant role in bone remodeling.
Purpose of the Study:
- To review current knowledge on the enteroendocrine-osseous axis.
- To specifically focus on the role of GIP in bone remodeling.
- To synthesize findings on GIP's impact on bone formation and resorption.
Main Methods:
- Review of observational and experimental studies.
- Analysis of genetic mutations affecting GIP receptor signaling.
- Examination of studies in rodent and human models.
- Assessment of bone turnover markers.
Main Results:
- Reduced GIP receptor signaling is associated with lower bone mineral density and higher fracture risk.
- GIP administration decreases serum levels of carboxy-terminal type 1 collagen crosslinks, a marker of bone resorption.
- GIP may stimulate bone formation, potentially uncoupling resorption and formation processes.
Conclusions:
- GIP is an important regulator within the enteroendocrine-osseous axis.
- GIP influences both bone resorption and formation, suggesting a dual role in bone metabolism.
- Further research into GIP's mechanisms could offer new therapeutic targets for bone diseases.
Related Concept Videos
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Physiology of Enteric Nervous System and Gut Health
Physiology of the Gastrointestinal System II: Digestion and Absorption
Digestion begins in the mouth, where food undergoes mechanical breakdown by chewing and combines with saliva. Salivary amylase, an enzyme in saliva, starts the breakdown of starches into maltose. The food then travels down the esophagus to the stomach.
In the stomach, a...
Gastrointestinal Motility Disorders

